SGRY — Surgery Partners Cashflow Statement
0.000.00%
Last trade - 00:00- $2.91bn
- $8.08bn
- $3.11bn
- 54
- 73
- 33
- 53
Annual cashflow statement for Surgery Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.3 | 70.7 | 87 | 135 | 12.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 96.8 | 57.8 | 95.8 | 106 | 122 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 75.9 | -149 | -161 | -63.5 | -119 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 247 | 87.1 | 159 | 294 | 300 |
| Capital Expenditures | -42.9 | -57.6 | -80.6 | -88.8 | -90.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -45.5 | -274 | -227 | -137 | -398 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -88.4 | -332 | -308 | -226 | -489 |
| Financing Cash Flow Items | -146 | -217 | -185 | -175 | -188 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 66.7 | 316 | 42.1 | -155 | 262 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 225 | 71.7 | -107 | -87 | 73.6 |